KEGG Pathway Maps

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level 

 Metabolism
 
 Genetic Information Processing
 
 Environmental Information Processing
 
 Cellular Processes
 
 Organismal Systems
 
 Human Diseases
 
 Drug Development
   Chronology: Antiinfectives
     07011  Penicillins
     07012  Cephalosporins - parenteral agents
     07013  Cephalosporins - oral agents
     07021  Aminoglycosides
     07019  Tetracyclines
     07020  Macrolides and ketolides
     07014  Quinolones
     07023  Rifamycins
     07026  Antifungal agents
     07044  Antiviral agents
     07053  Anti-HIV agents
   Chronology: Antineoplastics
     07040  Antineoplastics - alkylating agents
     07041  Antineoplastics - antimetabolic agents
     07042  Antineoplastics - agents from natural products
     07043  Antineoplastics - hormones
     07045  Antineoplastics - protein kinases inhibitors
   Chronology: Nervous system agents
     07032  Hypnotics
     07030  Anxiolytics
     07033  Anticonvulsants
     07015  Local analgesics
     07039  Opioid analgesics
     07028  Antipsychotics
     07029  Antipsychotics - phenothiazines
     07031  Antipsychotics - butyrophenones
     07027  Antidepressants
     07056  Agents for Alzheimer-type dementia
     07057  Antiparkinsonian agents
   Chronology: Other drugs
     07055  Sulfonamide derivatives - overview
     07016  Sulfonamide derivatives - sulfa drugs
     07017  Sulfonamide derivatives - diuretics
     07018  Sulfonamide derivatives - hypoglycemic agents
     07037  Antiarrhythmic drugs
     07038  Antiulcer drugs
     07046  Immunosuppressive agents
     07047  Osteoporosis drugs
     07048  Antimigraines
     07049  Antithrombosis agents
     07050  Antirheumatics - DMARDs and biological agents
     07051  Antidiabetics
     07052  Antidyslipidemic agents
     07054  Antiglaucoma agents
   Target-based classification: G protein-coupled receptors
     07220  Cholinergic and anticholinergic drugs
     07215  alpha-Adrenergic receptor agonists/antagonists
     07214  beta-Adrenergic receptor agonists/antagonists
     07213  Dopamine receptor agonists/antagonists
     07212  Histamine H1 receptor antagonists
     07227  Histamine H2/H3 receptor agonists/antagonists
     07211  Serotonin receptor agonists/antagonists
     07228  Eicosanoid receptor agonists/antagonists
     07224  Opioid receptor agonists/antagonists
     07229  Angiotensin receptor and endothelin receptor antagonists
   Target-based classification: Nuclear receptors
     07225  Glucocorticoid and mineralocorticoid receptor agonists/antagonists
     07226  Progesterone, androgen and estrogen receptor agonists/antagonists
     07223  Retinoic acid receptor (RAR) and retinoid X receptor (RXR) agonists/antagonists
     07222  Peroxisome proliferator-activated receptor (PPAR) agonists
   Target-based classification: Ion channels
     07221  Nicotinic cholinergic receptor antagonists
     07230  GABA-A receptor agonists/antagonists
     07036  Calcium channel blocking drugs
     07231  Sodium channel blocking drugs
     07232  Potassium channel blocking and opening drugs
     07235  N-Metyl-D-aspartic acid receptor antagonists
   Target-based classification: Transporters
     07233  Ion transporter inhibitors
     07234  Neurotransmitter transporter inhibitors
   Target-based classification: Enzymes
     07216  Catecholamine transferase inhibitors
     07219  Cyclooxygenase inhibitors
     07024  HMG-CoA reductase inhibitors
     07217  Renin-angiotensin system inhibitors
     07218  HIV protease inhibitors
   Structure-based classification
     07025  Quinolines
     07034  Eicosanoids
     07035  Prostaglandins
   Skeleton-based classification
     07110  Benzoic acid family
     07112  1,2-Diphenyl substitution family
     07114  Naphthalene family
     07117  Benzodiazepine family

[ BRITE | KEGG2 | KEGG ]
Last updated: August 21, 2018

» Japanese version